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Brief Technique Reportswith interarterial course and no intramural component, we
favor pulmonary artery translocation to create space be-
tween the aortic and pulmonic roots, thereby decreasing
the risk of pulmonary compression of the coronary artery.7
Intraoperative inspection determines which procedure will
be performed. If the orientation of the aortic and pulmonic
roots is such that anterior movement of the MPAwill create
space, a LeCompte maneuver is done. Alternatively, if mov-
ing the MPA laterally will create space, the MPA is translo-
cated distally toward the left pulmonary artery.
At the current time there is not sufficient data to form firm
management guidelines for asymptomatic children with
ACAs from the contralateral sinus. Because of the docu-
mented risk of sudden death without antecedent symptoms,
our policy is to surgically correct all lesions at risk, regard-
less of symptoms. Although we believe pulmonary artery
translocation is protective of subsequent ischemic episodes,
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anatomy. Ann Thorac Surg. 2001;72:2150-2.Quadruple valve replacement in patients with carcinoid heart diseaseArman Arghami, MD,a Heidi M. Connolly, MD,b Martin D. Abel, MD,c and Hartzell V. Schaff, MD,a
Rochester, MinnCarcinoid is a rare tumor of neuroendocrine cell lineage that
occurs in 1.2 to 2.1 persons per 100,000 per year.1 At diagno-
sis, 20% to 30% of patients have disseminated disease and
consequent carcinoid syndrome.2 Carcinoid heart disease af-
fects 40%ofpatients and remains a sourceofmajormorbidity
and mortality in carcinoid syndrome. Heart involvement is
thought to occur when serotonin and other active substances
are released from hepatic metastases or primary ovarian car-
cinoid tumors, thus bypassing metabolism in the liver.
Carcinoid heart disease typically involves tricuspid and
pulmonary valves, and patients often present with signs
and symptoms of right heart failure. Left-sided valve in-
volvement is reported infrequently (<10% of patients
with carcinoid heart disease)1 and is possibly due to metab-
olism of active substances by the lung. Thus, carcinoiddisease of the mitral and aortic valves may occur more
frequently in patients with an atrial septal defect or patent
foramen ovale (PFO) with right-to-left shunting of blood.
Left heart involvement may also occur in the absence of
an intracardiac shunt, perhaps with bronchopulmonary car-
cinoid or high levels of circulating serotonin.3 We describe
our experience with 7 patients who, because of carcinoid
heart disease, underwent quadruple valve replacement.CLINICAL SUMMARY
Between July 1989 and April 2010, 7 patients underwent
quadruple valve replacement for carcinoid heart disease at
Mayo Clinic, Rochester, Minnesota. This group comprised
4% of 168 patients who had valve surgery for carcinoid
heart disease and 23% of the 30 patients with concomitant
involvement of the mitral or aortic valves.RESULTS
All patients had clinical signs and symptoms of right and
left heart failure and echocardiographic evidence of carci-
noid heart disease, including thickened valves with regurgi-
tation. Right-sided valves had more severe involvement
than left except for 1 patient who had moderate tricuspid re-
gurgitation and severe regurgitation affecting the 3 other
valves. Intraoperative echocardiography identified a PFOgery c December 2010
TABLE 1. Outcomes of 7 patients with carcinoid heart disease who underwent quadruple valve replacement
Age,
y Gender
Maximum
5-HIAA,
mg/24 h
NYHA
Year of
surgery
CBP
time, min
Crossclamp,
min
Prosthesis
typePatient Preoperative Postoperative PFO Survival
1 59 M 517 3 2 1989 No 173 104 St Jude C´(St Jude Medical,
Inc, St Paul, MN) plus PH
39 mo
2 61 M 468 4 Died 1999 No 157 67 St Jude 6 d
3 79 M 170 3 2 2002 Yes 122 59 Carpentier-Edwards
(Edwards Lifesciences,
LLC, Irvine, CA)
5 mo
4 51 M 475 3 1 2006 Yes 61 7 CarboMedics, Inc, Austin, TX 30 mo
5 69 F 21.8 2 1 2009 No 200 75 St Jude Alive at FU
(6 mo)
6 61 M 192 3 2 2009 Yes 107 59 St Jude Alive at FU
(4 mo)
7 52 F 118 3 2 2009 No 133 67 CarboMedics, Inc Alive at FU
(3 mo)
CBP,Cardiopulmonary bypass;FU, follow-up; 5-HIAA, 5-hydroxyindoleacetic acid;NYHA,NewYorkHeart Association;PFO, patent foramen ovale; PH, pulmonary homograft.
Brief Technique Reportswith right-to-left shunting in 3 patients (43%) that was sur-
gically confirmed and repaired. Notably, no defects were
detected on preoperative transthoracic echocardiograms.
All patients had increased concentrations of urinary
5-hydroxyindoleacetic acid; levels were similar in patients
with or without a PFO (Table 1). Urinary 5-hydroxyindole-
acetic acid was only 21.8 mg/24 hours in the sole patient
(patient 5, Table 1) with primary ovarian carcinoid tumor.
Surgical Management
Six patients underwent replacement of all 4 valves during
1 operation; 1 patient (patient 4) had aortic andmitral valves
replaced with mechanical prostheses at another institution
for what was initially thought to be rheumatic heart disease.
Subsequently, he was found to have metastatic carcinoid
with right heart involvement and underwent tricuspid
and pulmonary valve replacement at the Mayo Clinic.
Right ventricular outflow tract reconstruction (pulmonary
augmentation) with pericardial patch was performed in 5
(71%) of 7 patients. During surgery, 6 patients receivedFIGURE 1. Posteroanterior and lateral chest radiographs of a patien
The Journal of Thoracic and Caroctreotide (median dose, 1.5 mg [range, 0.8-4 mg]). Supple-
mental octreotide was used in 3 patients during their stay in
intensive care (median dose, 2.3 mg [range, 0.5-5.2 mg]).
All excised valves had clinical and pathologic findings con-
sistent with carcinoid heart disease.
Surgical Outcomes
Four (57%) of the 7 patients had postoperative cardiac
arrhythmias (2 with atrial fibrillation; 2 with heart block),
and 1 patient required permanent pacing. One patient with
a preoperative creatinine concentration of 3.3 mg/dL had
transient worsening of renal insufficiency postoperatively
but did not require dialysis.
Follow-up Data
One patient died of heart failure 6 days postoperatively.
Functional improvement (eg, increased exercise tolerance,
reduced lower extremity edema, reduced ascites, resolution
of orthopnea, and paroxysmal nocturnal dyspnea) was
noted in all survivors. At last follow-up, left ventriculart with carcinoid heart disease after quadruple valve replacement.
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Brief Technique Reportsend-diastolic diameter was improved in 5 patients; right
ventricular size and function improved in 3 patients. Three
late deaths due to carcinoid progression occurred postoper-
atively at 39, 5, and 30 months.DISCUSSION
Previous studies have shown that tricuspid and pulmo-
nary valve replacement can improve symptoms and survival
in patients with right heart failure due to carcinoid heart
disease.1 Improved functional status and cardiac chamber
size were also noted in our carcinoid patients with 4 valve
replacements. Notably, a PFO was present in only 3 pa-
tients, and each was detected only by intraoperative transe-
sophageal echocardiography with saline injection. Thus,
our experience documents that an intracardiac shunt is not
necessary for development of left-sided carcinoid valve dis-
ease, despite other reports.4,5From the Department of Surgery I, Tokyo Women’s Medical University, Tokyo,
Japan.
Disclosures: None.
Received for publication April 30, 2010; accepted for publication May 11, 2010;
available ahead of print June 11, 2010.
Address for reprints: Masato Kanzaki, MD, Department of Surgery I, TokyoWomen’s
Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
(E-mail: kanzaki@chi.twmu.ac.jp).
J Thorac Cardiovasc Surg 2010;140:1434-6
0022-5223/$36.00
Copyright  2010 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2010.05.007
1434 The Journal of Thoracic and Cardiovascular SurCONCLUSIONS
Although carcinoid heart disease with involvement of all
4 valves is rare, we conclude that quadruple valve replace-
ment in symptomatic patients is a reasonable option that can
result in functional improvement with acceptable risks.
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1129.e1-6.Successful resection of localized pulmonary mucormycosis after bone
marrow transplantation using a virtual 3-dimensional pulmonary
model on a personal computerHideyuki Maeda, MD, Masato Kanzaki, MD, Tamami Isaka, MD, PhD, and Takamasa Onuki, MD, PhD,
Tokyo, JapanMucormycosis is a rare and fatal infectious disease. Pulmo-
narymucormycosismost often occurs in patients with neutro-
penia, immune deficiencies, malignant disease, malnutrition,
diabetes, and trauma, as well as in patients undergoing organ
transplantation or chelation therapy involving deferox-
amine.1,2 For control of the underlying disease, a polyene
administration and surgical resection of infected lung
segments may prove helpful. We report a case of localized
pulmonary mucormycosis after bone marrow transplantation
that was successfully resected using a virtual 3-dimensional
pulmonary model on a personal computer.CLINICAL SUMMARY
A 28-year-old man, treated with allogenic bone marrow
transplantation for acute lymphatic leukemia in March
2009, had progressive dyspnea and productive cough in
May 2009. Chest radiography and computed tomography
(CT) revealed a fungus ball in the left upper lobe of the
lung (Figure 1, A). Mucor was detected by bronchoscopic
biopsy. When liposomal amphotericin B (L-AMB) was ad-
ministered, the size of the fungus ball reduced immediately
(Figure 1, B). However, because the patient became resis-
tant to L-AMB, he was referred to our division for surgery
for pulmonary mucormycosis. Preoperative blood chemis-
try analysis showed pancytopenia and renal insufficiency
(the serum creatinine level 1.94 mg/dL) caused by ongoing
L-AMB administration. Chest CT demonstrated an 18-mm
cavitary mass in S1þ2c of the left lung. For preoperative
simulation of surgical resection, we used free software ap-
plication such as CTTRY, where we could mark on pulmo-
nary arteries, veins, bronchi, and fungus ball of the images
on high-resolution CT images. With 60 2-mm high-
resolution CT images of the fungus ball and hilum, in DI-
COM (Digital Imaging and Communications in Medicine)
format, we obtained 3-dimensional images for a patientgery c December 2010
